Siemens expands Gamma agreement:
This article was originally published in Clinica
Executive Summary
Malvern, Pennsylvania-based subsidiary of Siemens Medical Solutions has gained exclusive worldwide marketing rights to Gamma Medica's molecular imaging product, X-Spect, following an extension of the original agreement in July which had restricted Siemens' rights to the US. X-Spect is a dual modality system for pre-clinical imaging, combining functional nuclear imaging technique with anatomical imaging provided by computed tomography. Since the two companies signed the deal, rocketing sales of X-Spect have led Gamma Medica, of Northridge, California, to record a 400% increase in revenues during its fiscal 2004.